Please login to the form below

Not currently logged in
Email:
Password:

Pascale Richetta moves from AbbVie to UCB

She joins the biopharmaceutical company as executive vice president
Pascale Richetta

UCB has appointed Pascale Richetta to lead the global biopharmaceutical company's new bone patient value unit with effect from 1 February.

The unit was created last year with the development of UCB's patient value organisation and is currently led by its chief medical officer and head of the development of medical practices Iris Loew Friedrich.

In her new role Richetta will also serve at UCB as an executive vice president and member of the Belgium-based company's executive committee.

She has over 20 years of commercial and managerial experience in the pharmaceutical industry having worked with both traditional pharmaceuticals and complex biologics.

Richetta most recently served as vice president for Western Europe and Canada for AbbVie.

Prior to this, Richetta held managerial positions at Abbott, GSK, Ipsen and Servier where she was responsible for the international launch of each company's key drugs.

21st January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics